Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma

[1]  P. Kim,et al.  Efficacy and safety of ultrasound-guided implantation of fiducial markers in the liver for stereotactic body radiation therapy , 2017, PloS one.

[2]  Mary Feng,et al.  Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  J. Seong,et al.  Application of radiotherapy for hepatocellular carcinoma in current clinical practice guidelines , 2016, Radiation oncology journal.

[4]  S. Hussain,et al.  A Review and Update of Treatment Options and Controversies in the Management of Hepatocellular Carcinoma , 2016, Annals of surgery.

[5]  S. Yu,et al.  A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016 , 2016, Clinical and molecular hepatology.

[6]  J. Salleron,et al.  Stereotactic body radiation therapy as an ablative treatment for inoperable hepatocellular carcinoma. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[8]  E. Kunieda,et al.  Stereotactic body radiotherapy for small hepatocellular carcinoma: A retrospective outcome analysis in 185 patients , 2014, Acta oncologica.

[9]  Jong Hoon Kim,et al.  Stereotactic Body Radiation Therapy as an Alternative Treatment for Small Hepatocellular Carcinoma , 2013, PloS one.

[10]  Dong Han Lee,et al.  High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma , 2013, Radiation oncology.

[11]  Jong Hoon Kim,et al.  Two‐week schedule of hypofractionated radiotherapy as a local salvage treatment for small hepatocellular carcinoma , 2013, Journal of gastroenterology and hepatology.

[12]  Zahra Kassam,et al.  Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Dong Han Lee,et al.  Feasibility and Efficacy of Stereotactic Ablative Radiotherapy for Barcelona Clinic Liver Cancer-C Stage Hepatocellular Carcinoma , 2013, Journal of Korean medical science.

[14]  Dong Han Lee,et al.  Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization , 2012, Cancer.

[15]  Y. Jen,et al.  Stereotactic body radiation therapy in recurrent hepatocellular carcinoma. , 2012, International journal of radiation oncology, biology, physics.

[16]  A. Hezel,et al.  Stereotactic hypofractionated radiation therapy as a bridge to transplantation for hepatocellular carcinoma: clinical outcome and pathologic correlation. , 2012, International journal of radiation oncology, biology, physics.

[17]  H. El‐Serag,et al.  Epidemiology of viral hepatitis and hepatocellular carcinoma. , 2012, Gastroenterology.

[18]  M. Choi,et al.  Salvage treatment with hypofractionated radiotherapy in patients with recurrent small hepatocellular carcinoma. , 2012, International journal of radiation oncology, biology, physics.

[19]  Cynthia S. Johnson,et al.  Stereotactic body radiotherapy for primary hepatocellular carcinoma. , 2011, International journal of radiation oncology, biology, physics.

[20]  J. Bruix,et al.  Management of hepatocellular carcinoma: An update , 2011, Hepatology.

[21]  Y. Shibamoto,et al.  Hypofractionated Stereotactic Body Radiotherapy for Primary and Metastatic Liver Tumors Using the Novalis Image-Guided System: Preliminary Results regarding Efficacy and Toxicity , 2010, Technology in cancer research & treatment.

[22]  T. Lacornerie,et al.  Stereotactic Radiotherapy of Hepatocellular Carcinoma: Preliminary Results , 2010, Technology in cancer research & treatment.

[23]  M. Miften,et al.  Radiation-associated liver injury. , 2010, International journal of radiation oncology, biology, physics.

[24]  L Pagliaro,et al.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.

[25]  S. Kitano,et al.  Does portal hypertension contribute to the pathogenesis of gastric ulcer associated with liver cirrhosis? , 2000, Journal of Gastroenterology.

[26]  P. Mandrekar,et al.  American Association for the Study of Liver Diseases , 1993 .